companydata.dkcompanydata.dk

Valeos Pharma A/S: Financial statements 2025

CVR: 39696614

Source: annual report 2025, Danish Business Authority

01/01/2025 – 31/12/2025

Valeos Pharma A/S (CVR 39696614) has filed annual accounts for 2025. In 2025, the company reported a gross profit of DKK 975,949 and a net result of DKK -13,487,363 compared with DKK -16,944,710 the year before. Equity in the 2025 report amounted to DKK -6,687,169. The company had 19 employees in the financial year.

Gross Profit
DKK 975,949
Profit/Loss
DKK -13,487,363
Equity
DKK -6,687,169
Total Assets
DKK 52,838,008
Employees
19

Development

YearRevenueGross ProfitProfit/LossEquityEmployees
2025-976K-13.5M-6.7M19
2024--3.8M-16.9M6.8M19
2023--5.8M-16.5M-8.4M18
2022--6.5M-11.4M5.1M10
2021--3.4M-6.4M16.5M7

Official annual report

View the official annual report directly on the page with a Pro subscription.

How creditworthy is Valeos Pharma A/S?

See the CDS score and get a full credit report with recommended credit limit and payment terms.

Read about the CDS score

Events in 2025

Valeos Pharma A/S appoints new auditorSep 4, 2025

As of September 4, 2025, BDO Statsautoriseret Revisionspartnerselskab has been appointed auditor of Valeos Pharma A/S.

Auditor steps down at Valeos Pharma A/SSep 4, 2025

As of September 4, 2025, A/S PSE 17 NR. 1056 has stepped down as auditor of Valeos Pharma A/S.

Valeos Pharma A/S: The 2024 annual report is outJun 28, 2025

Valeos Pharma A/S has published its annual report for 2024. Gross profit came to DKK -3,846,790, and the net result was DKK -16,944,710.

Glenn Steven Nielsen joins the board of Valeos Pharma A/SJun 17, 2025

As of June 17, 2025, Glenn Steven Nielsen has joined the board of directors of Valeos Pharma A/S.

Henrik Kristian Moltke leaves the board of Valeos Pharma A/SJun 17, 2025

As of June 17, 2025, Henrik Kristian Moltke has left the board of directors of Valeos Pharma A/S.

Peter Frederik Andreasen joins Valeos Pharma A/S as adm. dir.May 26, 2025

As of May 26, 2025, Peter Frederik Andreasen is registered as adm. dir. of Valeos Pharma A/S.

Morten Larsen Snede steps down as adm. dir. of Valeos Pharma A/SMay 26, 2025

As of May 26, 2025, Morten Larsen Snede has stepped down as adm. dir. of Valeos Pharma A/S.

About Valeos Pharma A/S

Valeos Pharma A/S is a Danish company of the type Aktieselskab based in Holeby, founded in 2018. The company is registered under the industry Fremstilling af farmaceutiske præparater. The company was previously named Valeos A/S and Valeos ApS. The management consists of Peter Frederik Andreasen. The board consists of Glenn Steven Nielsen (chair), Kristian Schrøder Hart-Hansen, Michael Halborg-Bendtsen and Peter Frederik Andreasen. The company is owned by A. Rosen Holding ApS, MSG Capital APS and Kleingut ApS. The company has 21 employees (2026). In 2025, the company reported a gross profit of DKK 975,949 and a net result of DKK -13,487,363 compared with DKK -16,944,710 the year before. Equity in the 2025 report amounted to DKK -6,687,169.

Source: annual report 2025, Danish Business Authority

Other financial years